U.S. flag

An official website of the United States government

NM_138694.4(PKHD1):c.7202_7203dup (p.Gly2402fs) AND Polycystic kidney disease 4

Germline classification:
Likely pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001542751.2

Allele description [Variation Report for NM_138694.4(PKHD1):c.7202_7203dup (p.Gly2402fs)]

NM_138694.4(PKHD1):c.7202_7203dup (p.Gly2402fs)

Gene:
PKHD1:PKHD1 ciliary IPT domain containing fibrocystin/polyductin [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
6p12.2
Genomic location:
Preferred name:
NM_138694.4(PKHD1):c.7202_7203dup (p.Gly2402fs)
HGVS:
  • NC_000006.12:g.51885879_51885880dup
  • NG_008753.1:g.206746_206747dup
  • NM_138694.4:c.7202_7203dupMANE SELECT
  • NM_170724.3:c.7202_7203dup
  • NP_619639.3:p.Gly2402fs
  • NP_733842.2:p.Gly2402fs
  • NC_000006.11:g.51750677_51750678dup
Protein change:
G2402fs
Links:
dbSNP: rs2127551949
NCBI 1000 Genomes Browser:
rs2127551949
Molecular consequence:
  • NM_138694.4:c.7202_7203dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_170724.3:c.7202_7203dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Polycystic kidney disease 4 (PKD4)
Synonyms:
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3
Identifiers:
MONDO: MONDO:0033004; MedGen: C4540575; OMIM: 263200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001760183Genomics England Pilot Project, Genomics England
no assertion criteria provided

(ACGS Guidelines, 2016)
Likely pathogenicgermlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Genomics England Pilot Project, Genomics England, SCV001760183.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024